Azebiotics ApS: Financial statements 2023
CVR: 40503021
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Azebiotics ApS (CVR 40503021) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -103,696 and a net result of DKK -94,235 compared with DKK -92,244 the year before. Equity in the 2023 report amounted to DKK -522,182.
- Gross Profit
- DKK -103,696
- Profit/Loss
- DKK -94,235
- Equity
- DKK -522,182
- Total Assets
- DKK 50,369
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -104 t. | -94 t. | -522 t. | - |
| 2022 | - | -103 t. | -92 t. | -428 t. | - |
| 2021 | - | -143 t. | -123 t. | -336 t. | - |
| 2020 | - | -186 t. | -225 t. | -213 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Azebiotics ApS has published its annual report for 2022. Gross profit came to DKK -103,145, and the net result was DKK -92,244.
About Azebiotics ApS
Azebiotics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mikkel Bender. The company's owners include ECHOSTAR HOLDING ApS, MEVA HOLDING ApS and Frederik Ammitzbøll Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 67,779 and a net result of DKK 57,784 compared with DKK 176,367 the year before. Equity in the 2025 report amounted to DKK -288,030.